Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | JNJ-80038114 |
| Synonyms | |
| Therapy Description |
JNJ-80038114 targets prostate-specific membrane antigen (PSMA), potentially leading to T lymphocyte-mediated killing of tumor cells expressing PSMA (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| JNJ-80038114 | JNJ 80038114|JNJ80038114 | JNJ-80038114 targets prostate-specific membrane antigen (PSMA), potentially leading to T lymphocyte-mediated killing of tumor cells expressing PSMA (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05441501 | Phase I | JNJ-80038114 | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer | Completed | USA | GBR | 0 |